ZEB1: New advances in fibrosis and cancer

被引:0
|
作者
Lin Cheng
Ming-Yuan Zhou
Ying-Jian Gu
Lei Chen
Yun Wang
机构
[1] China Medical University,Department of Clinical Pharmacology, School of Pharmacy
来源
关键词
ZEB1; EMT; Cancer; Chemoresistance; Fibrosis; Protein structure;
D O I
暂无
中图分类号
学科分类号
摘要
Zinc finger E-box binding homeobox 1 (ZEB1) is an important transcription factor in epithelial mesenchymal transition (EMT) which participates in the numerous life processes, such as embryonic development, fibrosis and tumor progression. ZEB1 has multiple functions in human body and plays a crucial part in some life processes. ZEB1 is vital for the formation and development of the organs in the embryonic period. The abnormal expression of ZEB1 is a predictor for the poor prognosis or the poor survival in several cancers. ZEB1 contributes to the occurrence of fibrosis, cancer and even chemoresistance. Some research is indicated that fibrosis is finally developed into the cancers. Therefore, ZEB1 is probably taken as a biomarker in fibrosis or cancer. In this review, it is predicted of the structure of ZEB1 and the protein binding sites of ZEB1 with some protein, and it is discussed about the roles of ZEB1 in fibrosis and cancer progression to elaborate the potential applications of ZEB1 in clinic.
引用
收藏
页码:1643 / 1650
页数:7
相关论文
共 50 条
  • [21] lncRNAH19/ZEB1/EpCAM Regulatory Axis In Cholestatic Liver Fibrosis
    Song, Yongfeng
    Liu, Chune
    Wang, Li
    FASEB JOURNAL, 2017, 31
  • [22] ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM
    Zhang, Xiang
    Zhang, Zhen
    Zhang, Qing
    Zhang, Quansheng
    Sun, Peiqing
    Xiang, Rong
    Ren, Guosheng
    Yang, Shuang
    CELL DEATH & DISEASE, 2018, 9
  • [23] ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer
    Liu, Lingjia
    Tong, Qi
    Liu, Shuo
    Cui, Jianlin
    Zhang, Quansheng
    Sun, Wei
    Yang, Shuang
    PLOS ONE, 2016, 11 (02):
  • [24] E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
    Schmalhofer, Otto
    Brabletz, Simone
    Brabletz, Thomas
    CANCER AND METASTASIS REVIEWS, 2009, 28 (1-2) : 151 - 166
  • [25] Vasoactive intestinal polypeptide (VIP) regulates ZEB1 expression in cancer
    Rao, Ishani H.
    Dhamsania, Rohan
    Waller, Edmund K.
    Chandrasekaran, Sanjay
    CANCER RESEARCH, 2022, 82 (12)
  • [26] Elucidating the role of ZEB1 in metastatic castration resistant prostate cancer
    Sweeney, Katrina
    Stylianou, Nataly
    Fazli, Ladan
    Tevz, Gregor
    Pirlo, Katrina
    Upadhyaya, Akanksha
    Ratther, Ellca
    Lehman, Melanie
    Gleave, Martin
    Gunter, Jennifer
    Williams, Elizabeth D.
    Nelson, Colleen C.
    Hollier, Brett
    BJU INTERNATIONAL, 2016, 118 : 23 - 24
  • [27] E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
    Otto Schmalhofer
    Simone Brabletz
    Thomas Brabletz
    Cancer and Metastasis Reviews, 2009, 28 : 151 - 166
  • [28] ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer
    Irene Fernandez-De-Los-Reyes
    Marisa Gomez-Dorronsoro
    Iñaki Monreal-Santesteban
    Agustín Fernandez-Fernandez
    Mario Fraga
    Pablo Azcue
    Laura Alonso
    Beatriz Fernandez-Marlasca
    Javier Suarez
    Alicia Cordoba-Iturriagagoitia
    David Guerrero-Setas
    Clinical Epigenetics, 15
  • [29] Elucidating the role of ZEB1 in metastatic castration resistant prostate cancer
    Sweeney, Katrina
    Stylianou, Nataly
    Tevz, Gregor
    Pirlo, Katrina
    Upadhyaya, Akanksha
    Lehman, Melanie
    Fazli, Ladan
    Gleave, Martin
    Gunter, Jennifer
    Williams, Elizabeth D.
    Nelson, Colleen C.
    Hollier, Brett G.
    BJU INTERNATIONAL, 2015, 116 : 35 - 35
  • [30] ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer
    Fernandez-De-Los-Reyes, Irene
    Gomez-Dorronsoro, Marisa
    Monreal-Santesteban, Inaki
    Fernandez-Fernandez, Agustin
    Fraga, Mario
    Azcue, Pablo
    Alonso, Laura
    Fernandez-Marlasca, Beatriz
    Suarez, Javier
    Cordoba-Iturriagagoitia, Alicia
    Guerrero-Setas, David
    CLINICAL EPIGENETICS, 2023, 15 (01)